Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
Among the hep C population, other factors associated with chronic kidney disease include being older and having diabetes or HIV.
Will your hepatitis C treatment work if your doctor reduces your ribavirin dose?
The antiviral drug, which for some people can be a beneficial adjunct to the new crop of hep C medications, has gotten a bad rap.
The trial tested 16 and 24 weeks of grazoprevir/uprifosbuvir/ruzasvir among those with genotype 1 who had failed a previous treatment.
However, in a recent study those who had been treated for hep C before did not fare as well.
People on dialysis have a higher risk of anemia-related health complications if they have hepatitis C.
It’s been quite a ride. I can’t help but wonder what it’ll be like not to have ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin fl...
When I started Viekira Pak I wondered if the Week 3 voodoo would get me. It’s had a go, but failed so far. Here are the latest set of blood te...
A single pill of Sovaldi (sofosbuvir) and ledipasvir, with or without ribavirin, cured 96 percent of people with genotype 1 of HCV in...
Those taking AbbVie’s combo therapy virus who reduced their dose of ribavirin because of side effects, saw no reduction in their cure rates.
A novel version of interferon, pegylated interferon lambda-1a (peg-IFN-lambda), combined with ribavirin cured up to three-quarters of...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.